Patterson Companies

Patterson Cos., Inc. provides products, technologies, services, and business solutions to the dental and animal health markets. It operates through the following segments: Dental, Animal Health, and Corporate. The Dental segment provides consumable dental products, equipment and software, turnkey digital solutions, and value-added services to dentists, dental laboratories, institutions, and other healthcare professionals. The Animal Health segment distributes animal health products, services, and technologies to both the production-animal and companion-pet markets. The Corporate segment consists of general and administrative expenses, including home office support costs in areas such as information technology, finance, legal, human resources, and facilities. The company was founded by John Patterson and Myron Fayette Patterson in 1877 and is headquartered in St. Paul, MN.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Patterson Companies Inc. reports strong Q4 performance and outlines growth strategies for fiscal 2024

Patterson Companies Inc. delivered strong financial results for Q4 2023, with a focus on sustained margin improvement and strategic growth opportunities. Despite challenges in free cash flow and market moderation, the company is well-positioned to leverage its strengths and capitalize on opportunities in the dental and animal health segments.

Patterson Companies Inc. reports strong Q2 earnings and focuses on private label growth

Patterson Companies Inc. delivered strong financial performance in Q2 2023, driven by growth in both the Dental and Animal Health segments. The company reaffirmed fiscal '24 earnings guidance and highlighted the potential of private label products. Despite tax and interest rate challenges, the company remains optimistic and focused on strategic initiatives to drive future growth.

Patterson Companies excels in Q3, eyes international growth opportunities

Patterson Companies reported a strong Q3 performance with internal sales growth and margin improvements. Challenges in the Dental segment were offset by growth in the Animal Health segment. The company highlighted strategic acquisitions, leadership appointments, and operational enhancements as key drivers of success. Opportunities lie in stable patient traffic, international investments, and exploring M&A in dental specialties for future growth.

Patterson Companies reports strong Q4 performance and strategic growth focus

Patterson Companies had a robust Q4 performance, showcasing growth in sales and margins. Despite challenges in the companion animal market, the company is strategically positioned for growth through software investments and service enhancements. Opportunities lie in sustained sales growth, margin expansion, and strategic market positioning.

Patterson Companies reports strong Q1 results amidst strategic focus

Patterson Companies delivered strong Q1 '24 results with growth in sales and adjusted EPS. The company is strategically focusing on private label products and efficiency improvements. While facing challenges like deflationary impacts and inflationary pressures, Patterson sees opportunities in Dental equipment growth and continued investments for long-term profitability.

Patterson Companies reports strong Q2 performance amidst market challenges

Patterson Companies delivered a solid performance in Q2 2024, driven by growth in Dental and Animal Health segments.
Despite challenges like macroeconomic headwinds and pricing pressures, the company remains focused on efficiency and driving demand.
Opportunities exist for Patterson to capitalize on market trends, optimize operations, and explore new growth avenues.
Investors should monitor how Patterson navigates challenges and leverages strengths to achieve its revised fiscal guidance.

Patterson Companies reports solid Q3 performance amidst market challenges

Patterson Companies delivered a solid performance in Q3 2024, with a focus on revenue growth, margin expansion, and strategic investments in distribution and software offerings.
While facing challenges in certain segments, the company remains committed to operational efficiency, margin integrity, and long-term growth initiatives.
Opportunities lie in sustaining sales growth, expanding market presence, and capitalizing on improvements in equipment demand and margin enhancement.
Overall, Patterson's strategic focus on growth, efficiency, and innovation positions the company for long-term success in the market.

Patterson Companies Reports Stable Q4, Eyes Strategic Growth

Patterson Companies concluded fiscal 2024 with stable financial performance, facing some headwinds in the Dental segment but offset by gains in Animal Health and strategic tech investments. The company is poised for modest growth in 2025, backed by ongoing investments in high-margin areas and a strong focus on innovation and market expansion.

Patterson Companies addresses challenges in Q1 2025 earnings call

Patterson Companies faced challenges in Q1 2025, with declines in both the Dental and Animal Health segments.
Despite these challenges, management is taking actions to improve performance and profitability for the rest of fiscal 2025.
The company's focus on cost management and operational efficiency is a strength in navigating the current environment.
Opportunities exist in strengthening the companion animal business, improving internal sales, and enhancing cybersecurity measures.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Patterson Cos., Inc. engages in the provision of products, technologies, services, and business solutions to the dental and animal health markets. It operates through the following segments: Dental, Animal Health, and Corporate. The Dental segment provides consumable dental products, equipment and software, turnkey digital solutions, and value-added services to dentists, dental laboratories, institutions, and other healthcare professionals. The Animal Health segment distributes animal health products, services, and technologies to both the production-animal and companion-pet markets. The Corporate segment consists of general and administrative expenses, including home office support costs in areas such as information technology, finance, legal, human resources, and facilities. The company was founded by John Patterson and Myron Fayette Patterson in 1877 and is headquartered in St. Paul, MN.

Clorox

DexCom

Netflix

Teladoc

Virtu Financial

Zoom Video

When the Dow Jones industrial average has seen a drop of close to 3,000 points in less than a week, and with the new U.S.

8 Large-Cap Anti-Coronavirus Stock Winners During This Stock Market Sell-Off

Patterson Cos. (PDCO) delivered earnings and revenue surprises of 27.03% and 2.75%, respectively, for the quarter ended January 2020.

Patterson Cos. (PDCO) Q3 Earnings and Revenues Surpass Estimates

Patterson Cos. shares  rose 10% in premarket trade Thursday, after the medical supplies company beat earnings estimates for its fiscal third quarter.

Patterson Cos. shares soar 10% premarket after earnings top estimates, company lifts guidance

Patterson Companies (PDCO) stock may be a good choice for value-oriented investors right now from multiple angles.

Can Value Investors Consider Patterson Companies (PDCO)?

Patterson Companies, Inc. (PDCO) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

Moving Average Crossover Alert: Patterson Companies

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Should Value Investors Buy Patterson Cos. (PDCO) Stock?

West Pharmaceutical Services

PDCO vs. WST: Which Stock Is the Better Value Option?

PDCO or WST: Which Is the Better Value Stock Right Now?

Patterson Cos. (PDCO) reported earnings 30 days ago.

Why Is Patterson Cos. (PDCO) Down 11.8% Since Last Earnings Report?

Patterson Companies (PDCO) continues to benefit from robust product portfolio, strong prospects in Animal Health unit and strategic buyouts.

Here's Why You Should Invest in Patterson Companies Stock Now

Artisan Partners Asset Management

Delek Logistics Partners

Waddell & Reed Financial

A sneak peek into some possible value stock outperformers with a solid Zacks Rank, healthy dividend yield and a favorable Zacks Industry Rank will likely help investors in 2020.

4 Value Stocks With Solid Dividend Yield to Buy in 2020

Patterson Companies, Inc. (PDCO) CEO Mark Walchirk on Fiscal Q2 2020 Results - Earnings Call Transcript

Earnings beat, and they could keep on beating as the (fiscal) year progresses.

Why Patterson Companies Stock Popped 12% Today

Patterson Companies' (PDCO) Q2 results benefit from higher revenues, gross margin expansion and solid show by Dental segment.

Patterson Companies (PDCO) Q2 Earnings Surpass Estimates

Patterson Cos. (PDCO) delivered earnings and revenue surprises of 11.43% and 0.19%, respectively, for the quarter ended October 2019.

Patterson Cos. (PDCO) Beats Q2 Earnings and Revenue Estimates

Canadian Imperial Bank of Commerce

Xenia Hotels & Resorts

A little dividend income could go a long way in growing your portfolio

3  Stocks to Buy With Dividends Yielding More than 5%

Why Is Patterson Cos. (PDCO) Up 5.9% Since Last Earnings Report?

Patterson Companies (PDCO) continues to benefit from robust product portfolio, strong prospects in Animal Health unit and strategic buyouts. However, intense competition remains a woe.

Here's Why You Should Retain Patterson Companies (PDCO) Now

Henry Schein

DENTSPLY SIRONA

Dental practice management software helps dental businesses run smoothly by ensuring safe storage and easy access of critical information.

3 Best Dental Stocks to Keep An Eye On

Patterson Companies, Inc. (PDCO) CEO Mark Walchirk on Q1 2020 Results - Earnings Call Transcript

Patterson Companies' (PDCO) Q1 results benefit from higher revenues, gross margin expansion, solid show by Corporate segment and lower expenses.

Patterson Companies (PDCO) Earnings Beat Estimates in Q1

Patterson Cos. (PDCO) delivered earnings and revenue surprises of 8.00% and -2.87%, respectively, for the quarter ended July 2019.

Patterson Cos. (PDCO) Surpasses Q1 Earnings Estimates

Patterson Cos. (PDCO) Down 17.1% Since Last Earnings Report: Can It Rebound?

Patterson Companies (PDCO) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.

News for Patterson Companies Stock (PDCO)